Skip to main content
. 2022 Mar 3;6(5):1525–1535. doi: 10.1182/bloodadvances.2021004319

Table 3.

Multivariable HRs for NRM and OS

NRM OS
HR (95% CI) P HR (95% CI) P
SCI score
 0 Reference
 1 2.04 (1.11-3.74) .021 1.71 (1.13-2.59) .0105
 2 3.09 (1.66-5.73) .000 2.6 (1.7-3.97) <.001
 3 5.03 (2.64-9.6) .000 3.15 (1.95-5.07) <.001
 ≥ 4 7.04 (3.61-13.73) .000 4.08 (2.46-6.77) 0
Regimen
 Melphalan-based Reference
 TBI-based 0.89 (0.53-1.5) .670 1.03 (0.71-1.49) .888
Karnofsky performance status
 ≤ 80 Reference
 90 − 100 1.53 (1.08-2.17) .017 1.53 (1.17-2) .002
CIBMTR disease risk
 Low/Intermediate Reference
 High 1.05 (0.7-1.58) .818 1.31 (0.97-1.76) .078
 Unclassifiable 0.57 (0.27-1.18) .130 0.53 (0.28-0.98) .042
Recipient CMV serostatus
 Negative Reference
 Positive 1.13 (0.8-1.61) .491 1.19 (0.91-1.57) .197
Donor type
 Matched related Reference
 Matched unrelated 1.1 (0.73-1.65) .662 0.92 (0.68-1.24) .590
 Mismatched 2.4 (1.51-3.82) .000 1.7 (1.19-2.42) .003

CIBMTR, Center for International Blood and Marrow Transplant Research; CMV, cytomegalovirus.